Rituximab therapy in adults with steroid-dependent nephrotic syndrome
Introduction Patients with steroid-dependent nephrotic syndrome (SDNS) suffer frequent relapse with adverse effects caused by long-term prednisolone treatment. Recently, the chimeric monoclonal antibody against the protein CD20 (rituximab – RTX) was observed to be efficacious and safe in the treatme...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2019-10-01
|
| Series: | Archives of Medical Science |
| Subjects: | |
| Online Access: | https://www.archivesofmedicalscience.com/Rituximab-therapy-in-adults-with-steroid-dependent-nephrotic-syndrome,111931,0,2.html |